Leading the way to safer medication
 Crosscheck  Recommender

Insulin (human)

Description

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

ATC Classification

Code
Title
Category
A10AB01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
A10AC01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting
A10AD01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
A10AE01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
A10AF01
Insulin (human)
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AF Insulins and analogues for inhalation

Trade names

Trade name
Countries

Austria Netherlands

Australia Austria Cyprus France Netherlands

United States

Canada

Austria

Australia Canada Cyprus Singapore United Kingdom

Spain

Austria Cyprus France Netherlands Singapore

Austria France Netherlands United Kingdom

Australia Austria Cyprus France Netherlands

United States

Canada

Australia Austria Cyprus

France

Product Monographs

Monograph
Type
Country
ACTRAPID Solution for injection
MPI, EU: SmPC
HUMULIN I Suspension for injection in a vial
MPI, EU: SmPC
UK